跳至主要内容
临床试验/NCT03872414
NCT03872414已完成不适用

Emotion Study (Improving Neural Dysregulation in Advanced Age: A Neurofeedback Approach)/Substudy: Flexible Brain Study

University of Florida2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
2
主要终点
Change in BOLD signal response

研究概览

简要总结

The proposed research applies the highly innovative technology of real-time functional Magnetic Resonance Imaging (rtfMRI) to examine plasticity of brain-regulatory mechanisms related to cognitive and affective processing and to determine benefits for cognition and affect in young and older adults and in Parkinson Disease (PD) patients.

详细描述

There is increasing evidence that age-related alterations in brain function associated with affective processing and attention contribute to these motivational and emotional changes with age.

Based on these theoretical considerations as well as the previous study's data, the proposed research will apply well-tested emotion processing and attention paradigms to address the pivotal question of whether brain activity can be modulated in healthy aging and PD (in the substudy) via contingent rt-fMRI neurofeedback and whether this neuroregulatory modulation increases emotion processing and cognitive performance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Young adults
  • aged 18-35 years of age
  • native English speaker
  • at least 8th grade education
  • generally physically and neurologically healthy as determined by the Health Demographics Screener
  • eligible for MRI as determined by the MRI Eligibility Interview (including not being pregnant)
  • scores within normal limits on a cognitive screener (MoCA)
  • no indication of serious psychiatric disturbance including major depression (based on Mental Health Screener)
  • willing and able to give informed consent
  • Inclusion Criteria: Older adults
  • age 55-100 years of age
  • native English speaker
  • at least 8th grade education
  • generally physically and neurologically healthy as determined by the Health Demographics Screener
  • eligible for MRI as determined by the MRI Eligibility Interview
  • no indication of dementia based on score of 30 or above on the Telephone Interview for Cognitive Status and nonimpaired score on the Montreal Cognitive Assessment (MoCA -- score of 22 and above)
  • no indication of serious psychiatric disturbance including current major depression (based on Mental Health Screener)
  • willing and able to give informed consent
  • Inclusion Criteria: Parkinson patients
  • must meet criteria for diagnosis of idiopathic Parkinson disease according the UK Brain Bank by a movement trained neurologist.
  • age 55-100 years of age
  • native English speaker
  • at least 8th grade education
  • generally physically and neurologically healthy other than Parkinson disease
  • eligible for MRI as determined by the MRI Eligibility Interview
  • no indication of dementia based on cognitive screening measures (TICS -- score of 30 or above, and MoCa -- score of 22 and above)
  • no indication of serious psychiatric disturbance including current major depression
  • willing and able to give informed consent
  • Inclusion Criteria: Individuals with SCD and a family history of dementia or Alzheimer's disease
  • age 55-100 years of age
  • native English speaker
  • at least 8th grade education
  • generally physically and neurologically healthy as determined by the Health Demographics Screener
  • eligible for MRI as determined by the MRI Eligibility Interview
  • no indication of dementia based on score of 30 or above on the Telephone Interview for Cognitive Status and nonimpaired score on the Montreal Cognitive Assessment (MoCA -- score of 22 and above)
  • no indication of serious psychiatric disturbance including current major depression (based on Mental Health Screener)
  • willing and able to give informed consent
  • community-dwelling with subjective report of cognitive complaints with scores >16 on the Cognitive Change Index (CCI-20)
  • no evidence of dementia or mild cognitive impairment based on cognitive screening using the MoCA; scores must fall within normal limits for age, education, and sex
  • no psychometric evidence of neuropsychological impairment on a modified Neuropsychological Battery from the NACC Unified Data Set, version 3
  • score of 0 on the Global Clinic Dementia Rating (CDR) scale
  • normal functional behavior in terms of daily activities, based on the Functional Activities Scale (FAQ)
  • availability of an informant (over the phone) who can provide information about the participant's complaints using the informant version of the CCI-20, and corroborate normal activities of daily living on the FAQ and the CDR scale.

排除标准

  • Pregnant or possibly pregnant
  • Claustrophobia
  • Large pieces of metal in the body, particularly in the face and neck.
  • Piercings or metal implants that cannot be removed from the body
  • Surgery on the brain or any prior serious brain damage or disease
  • Dementia or severe cognitive disorders
  • use of antipsychotics, sedatives, or other medications with significant anticholinergic properties (due to potential influence on memory)
  • use of prescribed 'memory enhancing' medications such as Aricept or Namenda.

结局指标

主要结局

Change in BOLD signal response

时间窗: Baseline; Day 8

Change in blood-oxygen-level dependent (BOLD) signal response of the anterior cingulate cortex.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验